Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Haemorrhage | 2.2% - 11.9% | x | ||
Pain | 2.2% - 11.9% | x | ||
Pregnancy | 0% - 0.7% | x | ||
Abortion infected | x | |||
Anaemia | x | |||
Back pain | x | |||
Neoplasm malignant | x | |||
Dysmenorrhoea | x | |||
Leukorrhea | x | |||
Cramp muscle | x | |||
Pelvic infection | x | |||
Ectopic pregnancy | x | |||
Urticaria | x | |||
Vaginal inflammation | x | |||
Spotting menstrual | x | |||
Allergic skin reaction | x | |||
Dyspareunia | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |